目的 了解天津市腫瘤醫(yī)院門診口服抗腫瘤中成藥的使用情況，為促進(jìn)臨床合理使用中成藥提供參考。方法 隨機(jī)抽取天津市腫瘤醫(yī)院2016年門診14 381張抗腫瘤相關(guān)中成藥處方，進(jìn)行處方點(diǎn)評。結(jié)果 683張不合理處方中，60歲以上老年人占50.51%；主要分布于中醫(yī)科、頭頸科、乳腺科、簡易門診、肺科，共占83.90%；紫龍金片、博爾寧膠囊、回生口服液的不合格處方數(shù)較多，共占47.14%；按所抽取處方數(shù)計(jì)算，復(fù)方萬年青膠囊的不合格率最大，有10種藥物的不合格率均小于1%；存在的問題主要為臨床診斷不明確、用量超量、適應(yīng)證不適宜、聯(lián)合用藥不適宜4個(gè)方面。結(jié)論 天津市腫瘤醫(yī)院門診口服抗腫瘤中成藥處方不合格率不是很高，但仍存在一定問題，需要采取一些干預(yù)措施。

Objective To understand the usage situation of oral antitumor Chinese patent medicines in the outpatient department of Tianjin Tumour Hospital, so as to provide reference for clinical rational use of Chinese patent medicines. Methods Totally 14 381 prescriptions of Chinese patent medicine were randomly selected in Tianjin Tumour Hospital in 2016, and prescription comments were carried out. Results In 683 pieces of unreasonable prescriptions, patients over 60 years old accounted for 50.51%. The unreasonable prescriptions were mainly distributed in Department of traditional Chinese medicine, head and neck, breast, simple outpatient, and lung, accounting for 83.90%. The number of unqualified prescriptions of Zilongjin Tablets, Boerning Capsules, Huisheng Oral Liquid was the most, accounted for 47.14%. According to the selected prescription, the unqualified prescription rate of Compound Wannianqing Capsules was the highest, and the unqualified prescription rate of 10 drugs was less than 1%. The main four aspects of problems were that the clinical diagnosis was not clear, the dose was excessive, the indication was not suitable, and combination was not suitable. Conclusion The unqualified rate of oral antitumor Chinese patent medicines in the outpatient department of Tianjin Tumour Hospital is not very high, but there are still some problems, which needs to take some intervention measures.